KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Orphan Therapeutics, LLC Applauds For Trailblazer Lifetime Achievement Award September 19, 2017 How Gilead Lost $7.8B in October Alone November 2, 2017 Astellas, Vical's Lead CMV Vaccine Flunks Key Phase III Study January 21, 2018
